TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12610195

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (300 mg/d) during cisplatin chemotherapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Cisplatin chemotherapy alone
Number of subjects: 47
Study: 10951428

Group type: EXPERIMENTAL
Intervention: Lomax(R) (Julphar, United Arab Emirates)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Maxaquin(R) (Searle, S.A., UK)
Number of subjects: 18
Study: 8916958

Group type: EXPERIMENTAL
Intervention: International Index
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Proliferative activity (% S-phase)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: DNA aneuploidy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Median % S-phase
Number of subjects: 242
Study: 1897353

Group type: EXPERIMENTAL
Intervention: Spinal analgesia
Number of subjects: 28

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 28
Study: 6412224

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg three times daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of nifedipine and atenolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Atenolol 100 mg once daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30938089

Group type: EXPERIMENTAL
Intervention: Breathing retraining using Buteyko breathing techniques
Number of subjects: 169
Study: 28160272

Group type: EXPERIMENTAL
Intervention: Immediate initiation of antiretroviral therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Deferred initiation of antiretroviral therapy
Number of subjects: 85
Study: 26331791

Group type: EXPERIMENTAL
Intervention: 150 mg racemic venlafaxine (VLX)
Number of subjects: 24
Study: 24296958

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.3 μg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dexmedetomidine and Propofol
Number of subjects: 30
Study: 22976533

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 20
Study: 20154599

Group type: COMPARATOR
Intervention: Femoral catheterization
Number of subjects: 736

Group type: COMPARATOR
Intervention: Jugular catheterization
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Right jugular position
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Left jugular position
Number of subjects: 736

Group type: COMPARATOR
Intervention: Femoral site
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Jugular site
Number of subjects: 736

Group type: COMPARATOR
Intervention: Both sites
Number of subjects: 736
Study: 18606913

Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT; 90% of Hfmax)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Continuous moderate exercise (CME; 70% of Hfmax)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 15891811

Group type: EXPERIMENTAL
Intervention: Glue (Tissucol) used for mesh fixation on the left side
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sutures (prolene 2/0) used for mesh fixation on the right side
Number of subjects: 55
Study: 12408183

Group type: EXPERIMENTAL
Intervention: Phenylalanine-restricted diet maintained after age 6
Number of subjects: 125

Group type: COMPARATOR
Intervention: Diet discontinued after age 6
Number of subjects: 125
Study: 9887236

Group type: EXPERIMENTAL
Intervention: IFN-alpha plus ATRA (150 mg/m2/day orally in two divided doses)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: IFN-alpha plus 13cRA (1 mg/kg/day orally)
Number of subjects: 63
Study: 8005187

Group type: EXPERIMENTAL
Intervention: Pemirolast potassium (TBX) 10 mg twice daily at 12 h intervals
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sustained-release theophylline formulation 100 mg twice daily at 12 h intervals
Number of subjects: 7
Study: 2689493

Group type: EXPERIMENTAL
Intervention: Selective decontamination with polymyxin E, norfloxacin, amphotericin B and systemic antibiotic prophylaxis with trimethoprim
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (perioperative antimicrobial prophylaxis only)
Number of subjects: 100
Study: 29058023

Group type: EXPERIMENTAL
Intervention: TKA with tourniquet (Group A, n=43)
Number of subjects: 86

Group type: COMPARATOR
Intervention: TKA without tourniquet (Group B, n=43)
Number of subjects: 86
Study: 26660591

Group type: EXPERIMENTAL
Intervention: In-office prophylaxis paste and toothpaste at home both containing 8% arginine and calcium carbonate (Pro‐Argin(™) Technology)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Fluoride‐free prophylaxis paste and fluoride toothpaste
Number of subjects: 74
Study: 23786460

Group type: EXPERIMENTAL
Intervention: Suicide education intervention (2-hour duration)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normal suicide care support (control group)
Number of subjects: 74
Study: 22403308

Group type: EXPERIMENTAL
Intervention: 4 mg/kg oral artesunate for three days followed by artemether-lumefantrine
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 2 mg/kg oral artesunate for three days followed by artemether-lumefantrine
Number of subjects: 44
Study: 19056219

Group type: EXPERIMENTAL
Intervention: Furlong hydroxyapatite‐coated total hip arthroplasty
Number of subjects: 191

Group type: COMPARATOR
Intervention: Charnley cemented total hip arthroplasty
Number of subjects: 191
Study: 17554539

Group type: EXPERIMENTAL
Intervention: Maximum-tolerated doses (MTD) chemotherapy including 75 mg/m2 of cisplatin and 75 mg/m2 of docetaxel on day 1
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-dose metronomic (LDM) chemotherapy consisting of cisplatin 25 mg/m2 and docetaxel 25 mg/m2 given on weeks 1, 2, and 3
Number of subjects: 40
Study: 17056968

Group type: EXPERIMENTAL
Intervention: Pregabalin/Celecoxib combination (400 mg/150 mg 1 h before and 200 mg/150 mg 12 h after surgery)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg 1 h before and 200 mg 12 h after surgery)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pregabalin (150 mg 1 h before and 150 mg 12 h after surgery)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pregabalin/Celecoxib combination
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (1 h before and 12 h after surgery)
Number of subjects: 80
Study: 12970206

Group type: EXPERIMENTAL
Intervention: Early revascularization (n=40, <or=1 month)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Late revascularization (n=45, >1 month)
Number of subjects: 85
Study: 11384137

Group type: EXPERIMENTAL
Intervention: Left iliac fossa (LIF) puncture technique
Number of subjects: 93

Group type: COMPARATOR
Intervention: Midline puncture technique
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 93
Study: 9232298

Group type: EXPERIMENTAL
Intervention: Liposome-encapsulated tetracaine (LET) 5%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Eutectic mixture of local anaesthetics (EMLA)
Number of subjects: 40
Study: 7950112

Group type: EXPERIMENTAL
Intervention: Diffractive multifocal posterior chamber lens (IOL)
Number of subjects: 140
Study: 3300672

Group type: EXPERIMENTAL
Intervention: Induction of labor at 42 weeks gestation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 0
Study: 2204472

Group type: EXPERIMENTAL
Intervention: ZnSO4 (660 mg) per day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Medical starch (control)
Number of subjects: 46
Study: 1095121

Group type: EXPERIMENTAL
Intervention: Nafoxidine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Ethinyloestradiol
Number of subjects: 98
Study: 30617588

Group type: EXPERIMENTAL
Intervention: Improved cooking system (pellet and improved cookstove)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 144
Study: 28009638

Group type: COMPARATOR
Intervention: Neutral head position
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Head rotated 45° to the right
Number of subjects: 38
Study: 25911131

Group type: EXPERIMENTAL
Intervention: Parents with VLBW infants
Number of subjects: 403

Group type: COMPARATOR
Intervention: Parents with term infants
Number of subjects: 403
Study: 24001382

Group type: EXPERIMENTAL
Intervention: Formal sun protection education (two intensive instruction classes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (general advice about sun protection and broad-spectrum sunscreen)
Number of subjects: 0
Study: 21881160

Group type: EXPERIMENTAL
Intervention: NL‐1000 piezoelectric pedometer at Level 3 (2.9 MET)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: NL‐1000 piezoelectric pedometer at Level 4 (3.6 MET)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Actical accelerometer
Number of subjects: 114
Study: 20003405

Group type: EXPERIMENTAL
Intervention: Guideline intervention applied by occupational physicians for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Care as usual provided by control group
Number of subjects: 20
Study: 17276217

Group type: EXPERIMENTAL
Intervention: Open surgical repair
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conservative treatment with a fixed sling for 1 week followed by rehabilitation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 76
Study: 15507072

Group type: EXPERIMENTAL
Intervention: Analgesic use (any)
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Opioid analgesic use
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Functional impairment from pain
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Diagnosis or treatment for chronic pain
Number of subjects: 1801

Group type: EXPERIMENTAL
Intervention: Differences in analgesic use across organizations
Number of subjects: 1801
Study: 11411655

Group type: EXPERIMENTAL
Intervention: Transurethral needle ablation (TUNA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham therapy (urethrocystoscopy)
Number of subjects: 27
Study: 10710819

Group type: EXPERIMENTAL
Intervention: Carbohydrate loading (CHO1)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Carbohydrate loading (CHO2)
Number of subjects: 4

Group type: COMPARATOR
Intervention: No carbohydrate loading (C1)
Number of subjects: 4

Group type: COMPARATOR
Intervention: No carbohydrate loading (C2)
Number of subjects: 4
Study: 8142205

Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide
Number of subjects: 13

Group type: COMPARATOR
Intervention: Oral cyclophosphamide
Number of subjects: 13
Study: 2843305

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (10 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30574865

Group type: EXPERIMENTAL
Intervention: Tolterodine in extensive metabolizers (EMs)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Tolterodine in poor metabolizers (PMs)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional dataset
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Genotype-based stratified groups
Number of subjects: 70
Study: 27744739

Group type: EXPERIMENTAL
Intervention: Weight-loss program plus exercise (WL + E group, n=28)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Weight-loss program plus sham (WL + S group, n=27)
Number of subjects: 55
Study: 26258567

Group type: EXPERIMENTAL
Intervention: Model C - nurse or lay counselors offered and provided HTC before clinical consultation
Number of subjects: 79910

Group type: EXPERIMENTAL
Intervention: Model A - health care providers referred eligible patients to on-site HTC after clinical consultation
Number of subjects: 79910

Group type: EXPERIMENTAL
Intervention: Model B - health care providers offered and provided HTC during clinical consultation
Number of subjects: 79910

Group type: COMPARATOR
Intervention: All models combined
Number of subjects: 79910
Study: 23182987

Group type: EXPERIMENTAL
Intervention: ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stanford V
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 0
Study: 20850852

Group type: EXPERIMENTAL
Intervention: Wrapping of the pedicle omental flap around the esophagogastric anastomosis (Group A)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Stapled technique for esophagogastrectomy (Group B)
Number of subjects: 255
Study: 18155445

Group type: EXPERIMENTAL
Intervention: Adjunctive topiramate (TPM)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Adjunctive lamotrigine (LTG)
Number of subjects: 67
Study: 17063975

Group type: EXPERIMENTAL
Intervention: Dalteparin (50 IU anti‐Xa/kg, single intravenous bolus)
Number of subjects: 24
Study: 12668365

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Paroxetine 40 mg/day
Number of subjects: 566

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 566
Study: 11035679

Group type: EXPERIMENTAL
Intervention: 3.68 microm saline solution droplets inhaled for 30 s at 12 L/min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 3.68 microm saline solution droplets inhaled for 30 s at 31 L/min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.01 microm saline solution droplets inhaled for 30 s at 18 L/min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 1.01 microm saline solution droplets inhaled for 30 s at 38 L/min
Number of subjects: 9
Study: 9220416

Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 63
Study: 1621545

Group type: EXPERIMENTAL
Intervention: Intracavernous E1 prostaglandin E1 (E1‐PG) injection
Number of subjects: 70

Group type: COMPARATOR
Intervention: Papaverine
Number of subjects: 70
Study: 6326932

Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiotherapy (40 Gy, one fraction a day over 20 days)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 371
Study: 30560750

Group type: EXPERIMENTAL
Intervention: Cognitive data
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Electrophysiology, structural MRI, diffusion tensor imaging
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Multimodal analyses with cognition plus any combination of one or more of the remaining three modalities
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: None of the modalities
Number of subjects: 46
Study: 29779806

Group type: EXPERIMENTAL
Intervention: Common bean BRS Estilo (Group CB)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Common bean BRS Pontal (Group TBB)
Number of subjects: 29
Study: 26680217

Group type: EXPERIMENTAL
Intervention: Supplementary leaflet summarising the gist of the key information (Trial 1)
Number of subjects: 747856

Group type: EXPERIMENTAL
Intervention: Supplementary narrative leaflet describing people's stories (Trial 2)
Number of subjects: 747856

Group type: EXPERIMENTAL
Intervention: General practice endorsement of the programme on the invitation letter (Trial 3)
Number of subjects: 747856

Group type: EXPERIMENTAL
Intervention: Enhanced reminder letter with a banner reiterating the screening offer (Trial 4)
Number of subjects: 747856
Study: 24225338

Group type: EXPERIMENTAL
Intervention: miglitol (M-group; n=52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: nateglinide (N-group; n=52)
Number of subjects: 104
Study: 22506822

Group type: EXPERIMENTAL
Intervention: Culturally relevant web‐MI intervention (web‐MI) in English and Spanish
Number of subjects: 27
Study: 20388813

Group type: EXPERIMENTAL
Intervention: Computerized dental simulator (CDS) training (n=39)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Traditional preclinical dental training alone (n=36)
Number of subjects: 75
Study: 18758204

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 10
Study: 15940178

Group type: EXPERIMENTAL
Intervention: CO(2) laser application for sanation of trophic venous ulcers
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Early correction of upper vertical venous‐venous reflux
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Auto‐venous plastic reconstruction
Number of subjects: 94
Study: 12564815

Group type: EXPERIMENTAL
Intervention: Maxillomandibular fixation (54 patients)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Titanium miniplate fixation (49 patients)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (44 healthy individuals)
Number of subjects: 103
Study: 10364660

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound (CDUS) measuring renal resistive index (RI)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound (CDUS)
Number of subjects: 46
Study: 8834816

Group type: EXPERIMENTAL
Intervention: Praneem Vilci (PV)
Number of subjects: 18

Group type: COMPARATOR
Intervention: HSD-hCG vaccine
Number of subjects: 18
Study: 2255169

Group type: EXPERIMENTAL
Intervention: MK-927
Number of subjects: 24

Group type: COMPARATOR
Intervention: Betaxolol
Number of subjects: 24
Study: 435953

Group type: EXPERIMENTAL
Intervention: Complete bed rest
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full mobilisation with the affected knee in a firm splint
Number of subjects: 0
Study: 31644339

Group type: EXPERIMENTAL
Intervention: PO (unfed) misoprostol (5 μg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: PO (fed) misoprostol (5 μg/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PR misoprostol (5 μg/kg)
Number of subjects: 8
Study: 29357594

Group type: EXPERIMENTAL
Intervention: LAS41008 (dimethyl fumarate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25537177

Group type: EXPERIMENTAL
Intervention: OLM 80
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: OLM 20
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: AML 5
Number of subjects: 69
Study: 23424263

Group type: EXPERIMENTAL
Intervention: Acupuncture in combination with conventional therapy
Number of subjects: 852
Study: 20850849

Group type: EXPERIMENTAL
Intervention: Antibacterial soap
Number of subjects: 197

Group type: COMPARATOR
Intervention: Plain soap
Number of subjects: 197
Study: 18315424

Group type: EXPERIMENTAL
Intervention: Free gingival graft (FGG)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (CTG)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both CTG and FGG
Number of subjects: 23
Study: 17048209

Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg/day (3 mg/m2 in children)
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg/day (175 mg/m2 in children)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 378
Study: 12865034

Group type: EXPERIMENTAL
Intervention: Using 5 items in assessment
Number of subjects: 950

Group type: EXPERIMENTAL
Intervention: Using 50 items in assessment
Number of subjects: 950

Group type: EXPERIMENTAL
Intervention: Using at least 20 items in assessment
Number of subjects: 950
Study: 10938491

Group type: EXPERIMENTAL
Intervention: Patient education intervention
Number of subjects: 108
Study: 1444772

Group type: EXPERIMENTAL
Intervention: Concentric‐Eccentric Slow (MS)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Concentric‐Eccentric Fast (MF)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Concentric Slow (CS)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Concentric Fast (CF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 25
Study: 3912970

Group type: EXPERIMENTAL
Intervention: Oral acyclovir
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 30825341

Group type: EXPERIMENTAL
Intervention: Titanium brush
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (3% H2O2 and plastic ultrasonic scalers)
Number of subjects: 30
Study: 29102957

Group type: EXPERIMENTAL
Intervention: Stepwise dose increase of febuxostat from 10 to 40 mg/day
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg/day plus fixed-dose febuxostat 40 mg/day
Number of subjects: 241

Group type: COMPARATOR
Intervention: Fixed-dose febuxostat 40 mg/day
Number of subjects: 241
Study: 27824913

Group type: EXPERIMENTAL
Intervention: Anti-epileptic drugs (AEDs)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Trial AED compared with positive controls
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Delays in AED administration from seizure onset
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: RCTs in neonates treated with hypothermia
Number of subjects: 41
Study: 25458644

Group type: EXPERIMENTAL
Intervention: Pioglitazone (titrated from 15 to 45 mg/d)
Number of subjects: 3876

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 3876
Study: 21979312

Group type: EXPERIMENTAL
Intervention: HVLA thrust manipulation
Number of subjects: 107

Group type: COMPARATOR
Intervention: Nonthrust mobilization
Number of subjects: 107
Study: 20510973

Group type: EXPERIMENTAL
Intervention: Telecommunication-based Tai Chi exercise (Tele-ex)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Community center-based Tai Chi exercise (Comm-ex)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Home video-based Tai Chi exercise (Home-ex)
Number of subjects: 64
Study: 18833867

Group type: EXPERIMENTAL
Intervention: Nesiritide (0.01 mcg/kg/min) in addition to maximal standard therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Maximal standard therapy
Number of subjects: 34
Study: 16173377

Group type: EXPERIMENTAL
Intervention: No Conflict condition
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conflict condition
Number of subjects: 44
Study: 12185153

Group type: EXPERIMENTAL
Intervention: Combination therapy with lofepramine 70 mg and L-phenylalanine 500 mg twice daily, plus vitamin B-12 1 mg intramuscularly weekly.
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo (matching placebo tablets) plus vitamin B-12 1 mg intramuscularly weekly.
Number of subjects: 138
Study: 10094088

Group type: EXPERIMENTAL
Intervention: Intervention: Learning to terminate eating when flavor pleasantness subsided; duration: 1 month
Number of subjects: 7
Study: 8908233

Group type: EXPERIMENTAL
Intervention: 30 mg ketorolac IV before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo injection after surgery
Number of subjects: 60